In the U.S. alone, more than 6.7 million people have heart failure, a number that is projected to increase to more than 8.5 ...

Imbria Pharmaceuticals’ heart failure medicine met the safety and tolerability goals in a phase 2 trial while also improving results on a cardiopulmonary exercise test, with patients reporting other ...

LISBON, Portugal — Few people with suspected heart failure and elevated N-terminal prohormone of brain natriuretic peptide (NT-proBNP) levels are receiving a diagnosis after a year, reported ...

Patients over 65 account for most new cases of heart failure in the U.S., but, based on traditional risk factors, it’s hard for doctors to identify who is at highest risk for hospitalization or death.

Pennington Biomedical Research Center researchers at the Metamor Institute, along with colleagues from Our Lady of the Lake and LSU Health-New Orleans, have recently determined that metabolic surgery ...

In this Focus issue written by members of the EU-METAHEART collaboration, the authors explore the various ways in which metabolism is alterated in heart failure with either reduced or preserved ...